Pharmaceutical Companies in India
Indian Pharmaceutical Industry
At present there are almost 24 thousand companies in this industry with almost 330 companies in the organized sector. The top 10 companies hold almost 33.33 percent of the market. In 2012, the industry saw a year-on-year growth of almost 16 percent and is presently worth around 10 percent of the global industry in terms of volume and 1.4 percent with regards to worth.
Bio-pharmaceutical markets have lesser competition and the manufacturing process is rather complex. This is letting a number of companies focus in that area.
The 5 leading companies in this sector spend approximately 5 to 10 percent of their earnings in research and development related activities. However, in global circles this percentage is near 15 to 20 percent.
Indian companies have been taking various steps for their R&D operations like associating with innovators. Some other companies have changed their molecule license structure for making their milestone payments.
Some organizations are also preferring to make their research and development units into separate entities. However, with an overall decrease in research companies are now venturing into generics. In such a scenario the innovation-centric companies are purchasing such pharma houses or partnering with them.
Top 10 Pharmaceutical Companies In India
Ranbaxy Laboratories Limited became a public entity in 1973 after being incorporated during 1961. It is the largest pharmaceutical company in India. In 2011-12 it earned $2.1 billion around the world and its major market is North America.
Following are its top products:
- Ciprofloxacin and its combinations
- Ketorolac Tromethamine
- Atorvastatin and its combinations
- Co-amoxyclav and its combinations
- Loratadine and its combinations
Cipla was established during 1935 and its headquarters are at Mumbai. It has 20,000 employees and its revenue is $1.4 billion. It is among the biggest generic companies in the world and has more than 20,000 products, 40 dosage forms, and 65 therapy categories. Its products can be classed into three main categories:
Dr. Reddy’s started as a laboratory during 1984 as a maker of APIs. At present the company is worth at least $200 million and has more than 2700 employees and 3000 salesmen. Its products may be classified into the following:
- Global generics
- Differentiated formulations
- New chemical entities
Lupin is based in Mumbai and is presently worth $1.4 billion. The company’s EBITDA is 20 percent and going further up. Since 2005 it has been able increase its market capitalization 11 times and also increased its global presence. It is also one of the 25 top pharmaceutical companies of the world. Its products and services may be categorized as below:
- Branded formulations
- Advanced drug delivery systems
- Novel drug discovery and development
PV Ramaprasad Reddy, along with some dedicated medical professionals, and K Nityananda Reddy set up Aurobindo Pharma during 1986. At present the organization is one of the top 10 Indian companies when it comes to consolidated revenues. It also exports its products in 125 countries and gets 70% of its revenues from these operations. Its products may be classed into the following:
Sun Pharmaceutical is a global specialty pharmaceutical company and operates in 43 markets with significant presence in India and the US. The company commenced operations during 1983. It is the 5th biggest of its kind in India in terms of prescription sales. It specializes in API and Formulation drugs.
Cadila is based at Ahmedabad and is one of the largest privately owned pharma companies. The company operates in at least 90 countries and 45 product segments. It also has one of the finest R&D units in India. Following are its best brands:
- ACILOC RD
Jubilant Life Sciences is the biggest CRAMS organization in India and also one of the top drug discovery and development solution providers in the country. It is also the 6th biggest contract manufacturing and service based company in the world pharma industry. It also operates in North America, China, and Europe. In the pharmaceutical segment it offers the following:
- Active Pharmaceutical Ingredients
- CMO of Sterile and Non-sterile Products
- Solid Dosage Forms
- Drug Discovery and Development Solutions
- Allergy Therapy Products
Wockhardt is one of the leading multinational pharma houses based in India and has 7900 associates from 21 countries. Its head offices are in Mumbai and it also operates in the following countries:
- Sri Lanka
- Anti infectives
- Pain management
Ipca has been in the pharmaceutical business for at least 60 years and has operated in more than 110 countries across Africa, Europe, Asia, the US, and Australia. It makes 80 APIs and 350 formulations. It is one of the world leaders when it comes to making several APIs and in India is prominently known for its anti malaria medicine and Disease Modifying Anti-Rheumatic Drugs or DMARDs. It also occupies the top spot in several therapy areas.
In 2011-12 it earned INR 2,342.29 crores with a net profit of INR 280.17 crores. It has also been awarded for its work environment in a survey co-conducted by The Economic Times and Great Place to Work. Apart from the previously mentioned ones, it deals in Generics and Onyx Scientific medicines.
Some other leading pharmaceutical companies:
- Aventis Pharma
- Surya Pharma
- Torrent Pharma
- Divis Labs
- Orchid Chemical
- Abbott India
- Sterling Bio
- Alembic Pharma